Chemoinformaics analysis of TRANS-ALPHA-NECRODYL ACETATE
| Molecular Weight | 196.29 | nRot | 2 |
| Heavy Atom Molecular Weight | 176.13 | nRig | 6 |
| Exact Molecular Weight | 196.146 | nRing | 1 |
| Solubility: LogS | -3.292 | nHRing | 0 |
| Solubility: LogP | 3.574 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 34.9799 |
| nHD | 0 | BPOL | 22.6681 |
| QED | 0.501 |
| Synth | 3.793 |
| Natural Product Likeliness | 1.646 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.866 |
| Pgp-sub | 0.006 |
| HIA | 0.011 |
| CACO-2 | -4.449 |
| MDCK | 0.0000241 |
| BBB | 0.915 |
| PPB | 0.783551 |
| VDSS | 1.642 |
| FU | 0.305236 |
| CYP1A2-inh | 0.2 |
| CYP1A2-sub | 0.129 |
| CYP2c19-inh | 0.083 |
| CYP2c19-sub | 0.881 |
| CYP2c9-inh | 0.107 |
| CYP2c9-sub | 0.26 |
| CYP2d6-inh | 0.011 |
| CYP2d6-sub | 0.51 |
| CYP3a4-inh | 0.043 |
| CYP3a4-sub | 0.415 |
| CL | 5.687 |
| T12 | 0.239 |
| hERG | 0.003 |
| Ames | 0.07 |
| ROA | 0.035 |
| SkinSen | 0.109 |
| Carcinogencity | 0.053 |
| EI | 0.904 |
| Respiratory | 0.742 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.523678 |